| Bioactivity | MIP-1095 potently inhibits the glutamate carboxypeptidase activity of PSMA (Ki =0.24 nM)[1]. |
| CAS | 949575-22-8 |
| Formula | C19H25IN4O8 |
| Molar Mass | 564.33 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Shawn M Hillier, et al. Preclinical evaluation of novel glutamate-urea-lysine analogues that target prostate-specific membrane antigen as molecular imaging pharmaceuticals for prostate cancer. Cancer Res. 2009 Sep 1;69(17):6932-40. |